Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6005)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vaccaro V, Bria E, Sperduti I, Gelibter A, Moscetti L, Mansueto G, Ruggeri EM, Gamucci T, Cognetti F, Milella M. First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer. World J Gastroenterol 2013; 19(28): 4511-4519 [PMID: 23901226 DOI: 10.3748/wjg.v19.i28.4511] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v19/i28/4511.htm |
| Number | Citing Articles |
| 1 |
Eleonora Lucchini, Sara Pilotto, Elisa Spada, Davide Melisi, Emilio Bria, Giampaolo Tortora. Targeting the epidermal growth factor receptor in solid tumors: focus on safety. Expert Opinion on Drug Safety 2014; 13(5): 535 doi: 10.1517/14740338.2014.904283
|
| 2 |
Matias E. Valsecchi, Enrique Díaz-Cantón, Máximo de la Vega, Susan J. Littman. Recent Treatment Advances and Novel Therapies in Pancreas Cancer: A Review. Journal of Gastrointestinal Cancer 2014; 45(2): 190 doi: 10.1007/s12029-013-9561-z
|
| 3 |
Dongqing Wang, Haitao Zhu, Yanfang Liu, Qing Liu, Xiaodong Xie, Yuepeng Zhou, Lirong Zhang, Yan Zhu, Zhijian Zhang, Zhaoliang Su. The Low Chamber Pancreatic Cancer Cells Had Stem-Like Characteristics in Modified Transwell System: Is It a Novel Method to Identify and Enrich Cancer Stem-Like Cells?. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/760303
|
| 4 |
Monica Tang, Julia Chen, David Goldstein, Matthew Links, Sarah Lord, Ian Marschner, Robert J. Simes, Chee K. Lee. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer. Pancreas 2019; 48(10): 1274 doi: 10.1097/MPA.0000000000001429
|
| 5 |
Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios Theocharis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(13): 7053 doi: 10.3390/ijms22137053
|
| 6 |
Deepak Chitkara, Anupama Mittal, Ram I. Mahato. miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies. Advanced Drug Delivery Reviews 2015; 81: 34 doi: 10.1016/j.addr.2014.09.006
|
| 7 |
R. E. Kast. Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. SpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1441-5
|
| 8 |
Altaf Mohammed, Naveena Janakiram, Shubham Pant, Chinthalapally Rao. Molecular Targeted Intervention for Pancreatic Cancer. Cancers 2015; 7(3): 1499 doi: 10.3390/cancers7030850
|
| 9 |
Vanja Vaccaro, Isabella Sperduti, Sabrina Vari, Emilio Bria, Davide Melisi, Carlo Garufi, Carmen Nuzzo, Aldo Scarpa, Giampaolo Tortora, Francesco Cognetti, Michele Reni, Michele Milella. Metastatic pancreatic cancer: Is there a light at the end of the tunnel?. World Journal of Gastroenterology 2015; 21(16): 4788-4801 doi: 10.3748/wjg.v21.i16.4788
|
| 10 |
Mariarosaria Boccellino, Lucio Quagliuolo, Concetta Alaia, Anna Grimaldi, Raffaele Addeo, Giovanni Francesco Nicoletti, Richard Eric Kast, Michele Caraglia. The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity. Current Medical Research and Opinion 2016; 32(11): 1839 doi: 10.1080/03007995.2016.1211522
|